DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the MAX HEALTHCARE INS LTD (MAXHEALTH) share price today?

MAX HEALTHCARE INS LTD (MAXHEALTH) is trading at ₹1,089.9 on the NSE, down 0.76% on the day. Source: DocStoX.

What is the PE ratio of MAX HEALTHCARE INS LTD?

MAX HEALTHCARE INS LTD has a price-to-earnings (PE) ratio of 73.5 in the Healthcare sector.

What is the market capitalisation of MAX HEALTHCARE INS LTD?

MAX HEALTHCARE INS LTD has a market capitalisation of approximately ₹1,06,176 crore.

MAX HEALTHCARE INS LTD

F&O

MAXHEALTH·NSE·Healthcare

₹1,089.90▼ -8.30 (-0.76%)

Healthcare · Hospitals

Revenue compounding 22% a year

NIFTY 50NIFTY 100NIFTY 200

Day₹1081.20

₹1101.40

52W₹903

₹130247%

Open

₹1100.00

High

₹1101.40

Low

₹1081.20

Prev Close

₹1098.20

Volume

16.18L

VWAP

₹1089.32

Snapshot

Key fundamentals

Market Cap

₹1.06L Cr

P/E Ratio

73.54Expensive

P/B Ratio

9.97

EPS

₹14.82

Book Value

₹110.00

ROE

14.80%Average

ROCE

15.00%Decent

Dividend Yield

0.18%

Debt / Equity

0.32Moderate

Face Value

₹10.00

52W High

₹1301.70

52W Low

₹903.00

Sector

Healthcare

Industry

Hospitals

Avoid

None moatHigh uncertainty

Fair value estimate

₹130

▼ 88.1%downside

Trading at ₹1,090 — 88% above our estimate

BearFair valueBull

₹111₹130₹192

/100

Business quality — Solid

Growth 63Profitability 67Efficiency 18Valuation 42

Plain English

Our view

Revenue compounding 22% a year
Low debt relative to equity
Expensive — trades at 74× earnings

Strengths

Low debt relative to equity
Revenue compounding 22% over 3 years

Risks

Expensive — trades at 74× earnings
Fundamental red flags (Piotroski 2/9)

How we got there

Fair value methods

Residual income

15% ROE fading to 13% over ~3 yrs, on ₹110 book

₹113

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹192

Analyst target

No analyst coverage

—

Blended fair value₹130

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Revenue compounding 22% over 3 years

Bear case

Expensive — trades at 74× earnings
Fundamental red flags (Piotroski 2/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

73.5Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

14.8%Average

Above 15% is considered healthy for Indian equities

ROCE

15.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.32Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹1.06L Cr

P/B

9.97

EPS

₹14.82

Div Yield

0.18%

What changed

Recent changes

Foreign investors-3.6% stake last quarter
Domestic institutions+3.6% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 73.5×

Growth

Strong

+22% rev CAGR

Profitability

Healthy

14.8% ROE

Financial health

Comfortable

D/E 0.32

Momentum

N/A

No technicals

Today

Trading activity

Delivery %62.9%

Turnover₹17624.99L Cr

Trades40,097

VWAP₹1089.32

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+22.4%

+27.3%

10Y

+24.8%

Profit

+9.3%

—

10Y

—

EPS

+9.2%

—

10Y

—

Profile

Cons

Stock is trading at 10.0 times its book value
Tax rate seems low
Company has a low return on equity of 13.7% over last 3 years.
Company might be capitalizing the interest cost
Dividend payout has been low at 13.6% of profits over last 3 years

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Foreign investors sold 3.61 pts; domestic institutions added 3.63 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

24%

Promoter

Promoters

23.7%0.00

Public

4.5%-0.03

FII / FPI

41.8%-3.61

DII

29.9%+3.63

Quarterly trend

Ownership over time

Q1 FY27

Promoter23.71%

FII41.78%

DII29.95%

Public4.55%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

F&O